Talent4Boards - Great Talent builds Great Boards
– BELGIUM, Mont-Saint-Guibert – Celyad Oncology SA (EBR: CYAD | NASDAQ: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced the appointment of Dr. Marina Udier, Ph.D. to its Board of Directors. “I am very ...
Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors
Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors
From:: Celyad Oncology welcomes Dr. Marina Udier to its Board of Directors
Sorry, the comment form is closed at this time.